All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

PT Kalbe Farma Tbk. revenue reports

PT Kalbe Farma Tbk. financial reports, PT Kalbe Farma Tbk. annual revenue in 2020. When does PT Kalbe Farma Tbk. report revenue?
Add to widgets
Added to widgets

PT Kalbe Farma Tbk. total revenue, net income and dynamics of changes in US dollar today

Net revenue PT Kalbe Farma Tbk. is now 5 648 145 037 073 $. Information about net revenue is taken from open sources. The dynamics of PT Kalbe Farma Tbk. net revenue decreased by -165 008 319 539 $ from the last reporting period. PT Kalbe Farma Tbk. net income is now 657 300 635 219 $. The financial report chart shows the values from 30/06/2018 to 30/09/2019. PT Kalbe Farma Tbk. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. PT Kalbe Farma Tbk. total revenue on the graph is shown in yellow.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/09/2019 5 648 145 037 073 $ +6.61 % ↑ 657 300 635 219 $ +11.68 % ↑
30/06/2019 5 813 153 356 612 $ +8.34 % ↑ 663 095 254 418 $ +5.85 % ↑
31/03/2019 5 365 509 312 496 $ - 595 071 167 733 $ -
31/12/2018 5 396 004 924 398 $ - 652 698 375 268 $ -
30/09/2018 5 297 772 086 774 $ - 588 564 926 326 $ -
30/06/2018 5 365 623 295 240 $ - 626 426 704 532 $ -
Show:
to

PT Kalbe Farma Tbk. financial report charts

The latest dates of PT Kalbe Farma Tbk. financial statements available online: 30/06/2018, 30/06/2019, 30/09/2019. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of PT Kalbe Farma Tbk. for today is 30/09/2019. Gross profit PT Kalbe Farma Tbk. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit PT Kalbe Farma Tbk. is 2 552 932 972 631 $

PT Kalbe Farma Tbk. quarterly report dates

Cost of revenue PT Kalbe Farma Tbk. is the total cost of producing and distributing of products and services of a company. Cost of revenue PT Kalbe Farma Tbk. is 3 095 212 064 442 $ Total revenue PT Kalbe Farma Tbk. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue PT Kalbe Farma Tbk. is 5 648 145 037 073 $ Operating income PT Kalbe Farma Tbk. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income PT Kalbe Farma Tbk. is 880 008 224 248 $

Net income PT Kalbe Farma Tbk. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income PT Kalbe Farma Tbk. is 657 300 635 219 $ Current assets PT Kalbe Farma Tbk. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets PT Kalbe Farma Tbk. is 11 084 871 211 801 $ Total assets PT Kalbe Farma Tbk. refers to the total amount of assets owned by a person or entity. Total assets PT Kalbe Farma Tbk. is 19 593 943 644 192 $

30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 552 932 972 631 $ 2 631 153 270 017 $ 2 457 227 048 332 $ 2 302 400 579 841 $ 2 418 686 715 725 $ 2 492 459 634 065 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
3 095 212 064 442 $ 3 182 000 086 595 $ 2 908 282 264 164 $ 3 093 604 344 557 $ 2 879 085 371 049 $ 2 873 163 661 175 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
5 648 145 037 073 $ 5 813 153 356 612 $ 5 365 509 312 496 $ 5 396 004 924 398 $ 5 297 772 086 774 $ 5 365 623 295 240 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
880 008 224 248 $ 868 251 431 233 $ 773 187 666 825 $ 883 297 593 949 $ 750 127 680 652 $ 803 714 656 627 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
657 300 635 219 $ 663 095 254 418 $ 595 071 167 733 $ 652 698 375 268 $ 588 564 926 326 $ 626 426 704 532 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
65 919 406 922 $ 71 238 389 521 $ 61 246 056 662 $ 55 329 047 903 $ 60 025 312 657 $ 67 400 107 070 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
4 768 136 812 825 $ 4 944 901 925 379 $ 4 592 321 645 671 $ 4 512 707 330 449 $ 4 547 644 406 122 $ 4 561 908 638 613 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
11 084 871 211 801 $ 10 661 178 989 127 $ 11 326 325 659 911 $ 10 648 288 386 726 $ 10 322 941 876 272 $ 10 910 110 365 936 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
19 593 943 644 192 $ 18 813 050 576 863 $ 19 177 851 015 254 $ 18 146 206 145 369 $ 17 530 868 911 485 $ 17 892 981 267 652 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
2 611 412 930 955 $ 2 478 404 129 339 $ 3 201 308 324 265 $ 3 153 327 557 478 $ 2 528 943 903 418 $ 3 125 697 206 233 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
2 551 863 789 452 $ 2 658 377 795 816 $ 2 652 092 865 505 $ 2 286 167 471 594 $ 2 427 567 832 871 $ 3 382 316 838 392 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
3 458 042 857 031 $ 3 516 192 523 835 $ 3 320 263 540 428 $ 2 851 611 349 015 $ 2 952 878 830 588 $ 3 921 410 964 974 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
17.65 % 18.69 % 17.31 % 15.71 % 16.84 % 21.92 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
15 322 868 949 691 $ 14 664 889 864 198 $ 15 218 855 530 697 $ 14 623 457 976 061 $ 13 933 810 760 426 $ 13 339 534 145 048 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
669 199 029 107 $ 566 787 972 643 $ 320 393 605 656 $ 857 714 564 854 $ 1 086 702 863 759 $ 369 794 950 416 $

Last revenue report of PT Kalbe Farma Tbk. was 30/09/2019. According to last financial report total revenue in PT Kalbe Farma Tbk. was 5 648 145 037 073 US dollar and changed by +6.61% since last year. Net income in PT Kalbe Farma Tbk. was 657 300 635 219 $ in last quartal, net income changes to +11.68%.

Current cash PT Kalbe Farma Tbk. - the sum of all of the cash a company has on the date of report. Current cash PT Kalbe Farma Tbk. is 2 611 412 930 955 $ Current debt PT Kalbe Farma Tbk. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt PT Kalbe Farma Tbk. is 2 551 863 789 452 $ Total debt PT Kalbe Farma Tbk. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt PT Kalbe Farma Tbk. is 3 458 042 857 031 $

PT Kalbe Farma Tbk. stocks data

PT Kalbe Farma Tbk. financials